Journal of Meningitis
Open Access
Meningococcal vaccine
Search results for
Meningococcal vaccine
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
Useful Links
Related Subjects
Share This Page
Meningococcal vaccine
Meningococcal vaccine is mainly given against Neisseria meningitides. It consists of 13 clinically significant serogroups, based on the antigenic structure of their polysaccharide capsule. Out of these six serogroups, A, B, C, Y, W-135, and X, are responsible for virtually all cases of the disease in humans.
Related Journals of Meningococcal Vaccine
Journal of Meningitis, Clinical Infectious Diseases & Practice, Pediatric Infectious Diseases: Open Access, Bacteriology & Parasitology, Infectious Diseases & Therapy, Meningitis, Bacterial meningitis in children, Journal Neurology, Neurosurgery and Psychiatry, Emergency Medicine International, International Journal of Research in Medical Sciences
Meningococcal vaccine
Speaker PPTs
- Thomas Kieber-Emmons
Developing a first in man carbohydrate mimetic peptide vaccine for cancer: A translational story
| PDF Version - Ricardo Rosales
Vaccinia virus MVA as vector-vaccine strategy to modulate immune responses against Papillomavirus
PPT Version | PDF Version - Ganesh Raj Pant
A serological study in response to people at occupational risk of rabies virus exposure in Nepal
PPT Version | PDF Version - Daniela Pencheva
BUL BIO-NCIPD
PPT Version | PDF Version - Wendy peters
A non-replicating Ad5 vaccine for treatment of HSV-2
PPT Version | PDF Version - Randa Hamadeh
Polio returns to Middle East, situation analysis, strategies and way forward
PPT Version | PDF Version - Luiza Guilherme
Streptococcus pyogenes candidate vaccine
PPT Version | PDF Version - Xiao-Song He
Distinct priming effect of live attenuated versus inactivated influenza vaccines in repeated influenza vaccination
PPT Version | PDF Version - Gamal Wareth
Investigation and molecular typing of Brucella isolated from dairy cattle herd immunized with Brucella abortus RB51 vaccine in Egypt
PPT Version | PDF Version - Stephanie Ramos
Enhanced Delivery of Dna-Based Vaccines and Immunotherapeutics through Next-Generation Electroporation Devices
PPT Version | PDF Version - Manoj Kumar Chhikara
How promising is the development of a semi-synthetic meningococcal conjugate vaccine ?
| PDF Version - Charani ranasinghe
Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines
PPT Version | PDF Version - Sonia Escaich
Tat Oyi-based candidate therapeutic vaccine: a successful phase 1 clinical trial in HIV-1 infected patients
PPT Version | PDF Version - Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
PPT Version | PDF Version - Robert Lambkin-Williams
Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies. The manufacture of a new H3N2 virus for the human viral challenge model
PPT Version | PDF Version - Didier Betbeder
Nasal administration of antigens using maltodextrin nanoparticles: a mechanistic study
PPT Version | PDF Version - Carmen Alvarez-Dominguez
A dendritic cell targeted vaccine loaded with a GAPDH peptide confers wide protection to listeriosis in susceptible and resistant mice
| PDF Version - Zakaria Hmama
A non-genetic approach to improve the tuberculosis vaccine BCG
PPT Version | PDF Version - Filip Dubovsky
Development of a passive RSV vaccine for infants as an alternative to maternal vaccination
| PDF Version - Fu Shi Quan
Influenza virus-like particle vaccines elicit protective immunity in the early stage of vaccination
PPT Version | PDF Version - De-chu Christopher Tang
Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against infectious agents
PPT Version | PDF Version - Poonam Salotra
Development of genetically modifi ed live attenuated parasites as potential vaccines against visceral leishmaniasis
PPT Version | PDF Version - Ligia A. Pinto
Immune Responses to Human Papillomavirus Vaccines: What We Have Learned
PPT Version | PDF Version - Charles J. Russell
Sendai virus: illuminating parainfluenza virus dynamics in living animals and a platform for vaccine development
PPT Version | PDF Version - Chunxia Su
IL-2 as the adjuvant in FMD vaccine
PPT Version | PDF Version - Trevor R.F. Smith
Generation of robust immunity following DNA vaccine immunization enhanced by intradermal electroporation
PPT Version | PDF Version